BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Staging
5 results:

  • 1. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma.
    Joseph NM; Tsokos CG; Umetsu SE; Shain AH; Kelley RK; Onodera C; Bowman S; Talevich E; Ferrell LD; Kakar S; Krings G
    J Pathol; 2019 Jun; 248(2):164-178. PubMed ID: 30690729
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. MAF1 suppresses AKT-mTOR signaling and liver cancer through activation of pten transcription.
    Li Y; Tsang CK; Wang S; Li XX; Yang Y; Fu L; Huang W; Li M; Wang HY; Zheng XF
    Hepatology; 2016 Jun; 63(6):1928-42. PubMed ID: 26910647
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Low expression of FHIT and pten correlates with malignancy of gastric carcinomas: tissue-array findings.
    Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Tsuneyama K; Takano Y
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):432-40. PubMed ID: 18091387
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray.
    Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Miwa S; Tsuneyama K; Takano Y
    J Clin Pathol; 2007 Mar; 60(3):273-7. PubMed ID: 16714395
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival.
    Marsh JW; Finkelstein SD; Demetris AJ; Swalsky PA; Sasatomi E; Bandos A; Subotin M; Dvorchik I
    Liver Transpl; 2003 Jul; 9(7):664-71. PubMed ID: 12827550
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.